Aethlon Medical, Inc.
Aethlon Medical, Inc.
- Market cap
- $2.69M
Your view on AEMD
Overview
What the company does, where it operates, and who runs it.
About Aethlon Medical, Inc.
- Industry
- Medical - Devices
- Sector
- Healthcare
- CEO
- James B. Frakes
- Headquarters
- 11555 Sorrento Valley Road, San Diego, CA, US
- Industry
- Medical - Devices
- Sector
- Healthcare
- CEO
- James B. Frakes
- Headquarters
- 11555 Sorrento Valley Road, San Diego, CA, US
Aethlon Medical, Inc., a medical technology company, focuses on developing products to diagnose and treat life and organ threatening diseases in the United States.
The company develops Aethlon Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses from the human circulatory system, including removal of COVID-19 virus, associated variants, and related exosomes. Aethlon Medical, Inc. has a collaboration with the University of Pittsburgh Medical Center Hillman Cancer Center for studies related to head and neck cancer.
The company was founded in 1999 and is based in San Diego, California.
Stock Data
Price chart, volume, and trading data.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
About this section
Valuation, profitability, liquidity and leverage ratios for Aethlon Medical, Inc.. Starting points for Aethlon Medical, Inc.: EPS -$8.01, beta 1.40 — an Medical - Devices name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
About this section
Reported vs. expected earnings history for Aethlon Medical, Inc.. Trailing twelve-month EPS for Aethlon Medical, Inc. stands at -$8.01. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Wall Street Analyst Estimates
Analysts' price targets, ratings, and revenue and EPS estimates.
Price targets, ratings and estimates published by outside analysts. Not FRC research, not a recommendation, and not the FRC Fair Value: that is FRC's proprietary model, built on the cash a company generates.
Current price
—
live quote
Analysts' target
$1.50
average of analysts' targets
Analyst Ratings
- Strong Buy0
- Buy1
- Hold2
- Sell0
- Strong Sell0
Earnings Estimate
| EPS | Current QtrJun 2021 | Next QtrSep 2021 | Current YearFY Mar 2027 | Next YearFY Mar 2028 |
|---|---|---|---|---|
| Avg. estimate | −$104.00 | −$120.00 | −$6.49 | −$1.91 |
| Low estimate | −$104.00 | −$120.00 | −$11.93 | −$1.91 |
| High estimate | −$104.00 | −$120.00 | −$1.04 | −$1.91 |
| No. of analysts | 9 | 7 | 2 | 1 |
| Year-ago EPS | — | — | −$10.611 | — |
| Growth | — | — | — | — |
1Year-ago EPS includes one-time items; growth not shown.
Revenue Estimate
| Revenue | Current QtrJun 2021 | Next QtrSep 2021 | Current YearFY Mar 2027 | Next YearFY Mar 2028 |
|---|---|---|---|---|
| Avg. estimate | $175000.00 | $208500.00 | $0.00 | $0.00 |
| Low estimate | $175000.00 | $208500.00 | $0.00 | $0.00 |
| High estimate | $175000.00 | $208500.00 | $0.00 | $0.00 |
| No. of analysts | 5 | 5 | 0 | 0 |
| Year-ago revenue | — | — | $0.00 | — |
| Growth | — | — | — | — |
Source: Wall Street analysts' published price targets, ratings and estimates, compiled by Financial Modeling Prep from StreetInsider; as of Nov 20, 2026. Not FRC research or a recommendation.
Financial Statements
Income statement, balance sheet, and cash flow statements.
About this section
Income statement, balance sheet and cash flow history for Aethlon Medical, Inc.. Aethlon Medical, Inc. has reported as a listed company since 1999. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
| Ticker | Type | Company | Sector | Industry | Mkt cap |
|---|---|---|---|---|---|
| ALURAllurion Technologies Inc. | Healthcare | Medical - Devices | $11.0M | ||
| CODXCo-Diagnostics, Inc. | Healthcare | Biotechnology | $1.5M | ||
| ERNAErnexa Therapeutics Inc. | Healthcare | Biotechnology | $2.7M | ||
| LNAILunai Bioworks Inc. | Healthcare | Biotechnology | $829,677 | ||
| NVNOenVVeno Medical Corporation | Healthcare | Medical - Devices | $4.0M | ||
| TNONTenon Medical, Inc. | Healthcare | Medical - Devices | $526,243 | ||
| Ticker | Type | Company | Sector | Exchange | Mkt cap |
|---|---|---|---|---|---|
| NPCENeuroPace, Inc. | Healthcare | NASDAQ | $283.2M | ||
| NSPRInspireMD, Inc. | Healthcare | NASDAQ | $31.9M | ||
| NSYSNortech Systems Incorporated | Healthcare | NASDAQ | $32.8M | ||
| NUMDNu-Med Plus, Inc. | Healthcare | OTC | $1.3M | ||
| NUWENuwellis, Inc. | Healthcare | NASDAQ | $353,130 | ||
| NVCRNovoCure Limited | Healthcare | NASDAQ | $1.3B | ||
| NWCINewCardio, Inc. | Healthcare | OTC | $3,315 | ||
| NXLNexalin Technology, Inc. | Healthcare | NASDAQ | $1.8M | ||
| OCPNFOlympus Corporation | Healthcare | OTC | $10.6B | ||
| ODYYOdyssey Health, Inc. | Healthcare | OTC | $5.5M | ||
| OFIXOrthofix Medical Inc. | Healthcare | NASDAQ | $269.4M | ||
Institutional Ownership
Which funds and firms own the stock.
About this section
Which institutions hold Aethlon Medical, Inc., and how their positions are changing. At a $2.7M market value, institutional positions materially move Aethlon Medical, Inc.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings.
Insider Trading
Recent buying and selling by company executives.
About this section
Buying and selling by Aethlon Medical, Inc. executives and directors. Shares of Aethlon Medical, Inc. have traded between $3.90 and $84.80 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned.
News
Latest headlines and market coverage.
About this section
Latest headlines and company announcements for Aethlon Medical, Inc.. Coverage tracks Aethlon Medical, Inc. within Medical - Devices (Healthcare). Press releases and market coverage, newest first.

Comments
Comments and replies from FRC members about this company.
No comments yet
Be the first to ask a question or say what you make of Aethlon Medical, Inc.